Markets open

Ionis Pharmaceuticals, Inc.

IONS · NASDAQ-GS

Symbol: IONS
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: North America
Exchange: NASDAQ-GS

For more than three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis has marketed medicines and a leading pipeline in neurology, cardiometabolic disease and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients.

Key Issues

Bullish view

TipRanks reports 18 analysts with an average 12-month target of $90.13 and a high target of $115, indicating that published expectations remain materially above the $58.09 prior close.

Bearish view

HC Wainwright reduced its target from $115 to $100 and the shares opened at $52.15 after the downgrade, showing that at least one analyst became less constructive and that sentiment is sensitive to valuation or outlook changes.